Search This Blog

Friday, November 30, 2018

Karyopharm initiated at B. Riley FBR


Karyopharm initiated with a Buy at B. Riley FBR. B. Riley FBR analyst Harshita Polishetty started Karyopharm Therapeutics with a Buy rating and $23 price target.
https://thefly.com/landingPageNews.php?id=2830607

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.